Remove 2025 Remove Blood Pressure Remove Diabetes
article thumbnail

Medtronic Presents New Data, Clinical Milestones at CRT 2025

DAIC

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

article thumbnail

New Study to Examine Hypercortisolism in Resistant Hypertension

DAIC

tim.hodson Tue, 03/11/2025 - 11:19 Mar. 10, 2025-- Corcept Therapeutics Inc., Resistant hypertension is defined by the American Heart Association as elevated blood pressure despite the use of three or more antihypertensive medications in different classes, including a diuretic.

article thumbnail

PAD Pulse Alliance Urges Screening During American Heart Month

DAIC

tim.hodson Tue, 02/04/2025 - 17:13 Feb. 3, 2025 Today, Peripheral Artery Disease (PAD)affects 10 million Americans and is the most common cause of limb amputation outside of trauma. If you have a history of diabetes, high blood pressure, or tobacco use, you should talk to your doctor about being screened for PAD.

article thumbnail

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25

DAIC

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Additional ACC.25

article thumbnail

Abstract TP266: Vascular disease risk and increased adherence to remote blood pressure monitoring. Data from the Skills-Based Educational strategies for Reduction of Vascular Events in Orange County, Ca (SERVE OC) Trial

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP266-ATP266, February 1, 2025. Effective blood pressure (BP) management is crucial for reducing stroke and CVD risk, yet controlled hypertension remains suboptimal especially among minority populations. Background:Stroke is the 5thleading cause of death in the U.S. SD=15.8); 63.8%

article thumbnail

Medtronic Presents New Data, Clinical Milestones

DAIC

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

article thumbnail

Impact of Conventional Stroke Risk Factors on Early- and Late-Onset Ischemic Stroke: A Mendelian Randomization Study

Stroke Journal

Stroke, Volume 56, Issue 3 , Page 640-648, March 1, 2025. BACKGROUND:Stroke incidence is decreasing in older ages but increasing in young adults. The causal effect of body mass index on stroke was significantly stronger for EOS than for LOS (odds ratio, 1.26 versus 1.03;P=0.008).